| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate |
2015-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d6b25009976f990fc500afb541a1396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9606829ee42c468b275e086e5682a97 |
| publicationDate |
2018-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-031089-B1 |
| titleOfInvention |
CRYSTALLINE (2S) -3 - [(3S, 4S) -3 - [(1R) -1-HYDROXYETHYL] -4- (4-METHOXY-3 - {[1- (5-METHYLPYRIDIN-2-IL) AZETIDIN- 3-IL] OXY} PHENYL-3-Methylpyrrolidine-1-IL] -3-OXOPROPAN-1,2-DIOL |
| abstract |
Crystalline (2S) -3 - [(3S, 4S) -3 - [(1R) -1-hydroxyethyl] -4- (4-methoxy-3 - {[1- (5-methylpyridin-2-yl) azetidine) is described. -3-yl] oxy} phenyl) -3-methylpyrrolidin-1-yl] -3-oxopropane-1,2-diol and its pharmaceutical compositions. The invention also describes methods of using this compound for the treatment of bladder hyperactivity. |
| priorityDate |
2014-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |